SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020011
Filing Date
2022-05-13
Accepted
2022-05-13 09:25:19
Documents
79
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20220331.htm   iXBRL 10-Q 1640819
2 EX-31.1 acor-ex311_9.htm EX-31.1 16407
3 EX-31.2 acor-ex312_6.htm EX-31.2 16035
4 EX-32.1 acor-ex321_8.htm EX-32.1 6656
5 EX-32.2 acor-ex322_7.htm EX-32.2 6708
  Complete submission text file 0001564590-22-020011.txt   7828578

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20220331.xsd EX-101.SCH 58490
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20220331_cal.xml EX-101.CAL 58091
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20220331_def.xml EX-101.DEF 196736
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20220331_lab.xml EX-101.LAB 488720
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20220331_pre.xml EX-101.PRE 370304
73 EXTRACTED XBRL INSTANCE DOCUMENT acor-10q_20220331_htm.xml XML 1438518
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 22920562
SIC: 2836 Biological Products, (No Diagnostic Substances)